Bankrupt DNA testing company 23andMe to be bought by RegeneronBy FinMar NewsMay 19, 2025Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million USD through a bankruptcy auction, the companies said on Monday.Regeneron said it will comply with 23andMe’s privacy policies…
